Logo-npj

Original

1. Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
Alireza Sadeghi, Aiyoub Pezeshgi, Arezoo Karimimoghaddam, Minoosh Moghimi, Koorosh Kamali, Mahsa Naseri, Abdolreza Esmaeilzadeh*
J Nephropharmacol. 2017;6(2): 98-105. doi: 10.15171/npj.2017.12
Article
PDF
XML
Cited By:
2
Epidemiology and Prevention

2. The guiding evidence based therapy using biomarker intensified treatment in heart failure (GUIDE-IT) study; the utility of decongestive diuresis in type 1 cardiorenal syndrome with rising pro-BNP levels 
Macaulay Amechi Chukwukadibia Onuigbo*
J Nephropharmacol. 2018;7(2): 66-67. doi: 10.15171/npj.2018.15
Article
PDF
XML
Cited By:
0
Review

3. Kidney injury molecule-1; is it a predictive marker for renal diseases?
Deepashree Goravigere Anandkumar ORCID, Prashant Chippalkatti Dheerendra ORCID, Deepesh Vellakampadi ORCID, Gnanasambandan Ramanathan* ORCID
J Nephropharmacol. 2023;12(2): e10572. doi: 10.34172/npj.2023.10572
Scopus ID: 85162141996    
Article
PDF
XML
Cited By:
0
0